¹⁶¹Tb-PSMA Radioligand Therapy: First-in-Humans SPECT/CT Imaging

J Nucl Med. 2023 Aug;64(8):1322-1323. doi: 10.2967/jnumed.122.265291. Epub 2023 Feb 9.

Authors

Akram Al-Ibraheem¹, Rahma M Doudeen², Diyaa Juaidi², Alaa Abufara³, Stephan Maus⁴

Affiliations

¹ Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan; [email protected].
² Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
³ Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; and.
⁴ Department of Nuclear Medicine, Universitätsklinikum des Saarlandes, Homburg, Germany.

PMID: 36759201
DOI: 10.2967/jnumed.122.265291

No abstract available

MeSH terms

Humans
Male
Positron Emission Tomography Computed Tomography / methods
Prostate-Specific Antigen
Single Photon Emission Computed Tomography Computed Tomography*
Tomography, Emission-Computed, Single-Photon* / methods

Substances

Prostate-Specific Antigen